A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

This publication has 34 references indexed in Scilit:

• Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency
  Clinical Chemistry, 2012
• Molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Hong Kong Chinese patients
  Steroids, 2011
• Sequence Analysis of CYP21A1P in a German Population to Aid in the Molecular Biological Diagnosis of Congenital Adrenal Hyperplasia
  Clinical Chemistry, 2011
• Analysis of the CYP21A2 Gene with Intergenic Recombination and Multiple Gene Deletions in the RCCX Module
  Genetic Testing and Molecular Biomarkers, 2011
• Functional characterization of threeCYP21A2sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system
  Human Mutation, 2008
• Microconversion betweenCYP21A2andCYP21A1PPromoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency
  The Journal of Clinical Endocrinology & Metabolism, 2007
• CYP21 Genotype, Adult Height, and Pubertal Development in 55 Patients Treated for 21-Hydroxylase Deficiency
  The Journal of Clinical Endocrinology & Metabolism, 2003
• Three Novel Mutations in CYP21 Gene in Brazilian Patients with the Classical Form of 21-Hydroxylase Deficiency Due to a Founder Effect
  The Journal of Clinical Endocrinology & Metabolism, 2002
• 21-Hydroxylase deficiency in Brazil
  Brazilian Journal of Medical and Biological Research, 2000
• Low Frequency of CYP21B Deletions in Brazilian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
  Human Heredity, 1999